Publications

Any
    Option:
    Any
    Any
      Option:
      Any

      5599 Results

      Phase II studies of hydroxyurea (NSC-32065) in adults: Leukemia

      Authors
      CC Shullenberger
      Journal / Conference
      Cancer Chemotherapy Reports 40:49-50
      Year
      1964
      Research Committee(s)
      Leukemia

      Phase II studies of hydroxyurea (NSC-32065) in adults: Carcinoma of the lung.

      Authors
      JN Bickers
      Journal / Conference
      Cancer Chemotherapy Reports 40:45-46
      Year
      1964
      Research Committee(s)
      Lung

      Phase II studies of hydroxyurea (NSC-32065) in adults: Multiple myeloma and lymphoma.

      Authors
      P Davis
      Journal / Conference
      Cancer Chemotherapy Reports 40:51-52
      Year
      1964
      Research Committee(s)
      Lymphoma and Myeloma

      Erythrokinetic abnormalities with administration of hydroxyurea (NSC-32065).

      Authors
      CP Alfrey Jr;RJ Karjalan;SC Dale;EP Frenkel;M Lane
      Journal / Conference
      Cancer Chemotherapy Reports 40:27-30
      Year
      1964

      Megaloblastic erythropoiesis induced by hydroxyurea.

      Authors
      DE Bergsagel;EP Frenkel;CP Alfrey Jr;WG Thurman
      Journal / Conference
      Cancer Chemotherapy Reports 40:15-17
      Year
      1964

      Pediatric clinical trials with hydroxyurea (NSC-30265).

      Authors
      DJ Fernbach
      Journal / Conference
      Cancer Chemotherapy Reports 40:37-38
      Year
      1964

      Studies on a metabolic defect induced by hydroxyurea (NSC-30265).

      Authors
      EP Frenkel;WN Skinner;JD Smiley
      Journal / Conference
      Cancer Chemotherapy Reports 40:19-22
      Year
      1964

      Hydroxyurea (NSC-32065): Results of a Phase I study.

      Authors
      KM Griffith
      Journal / Conference
      Cancer Chemotherapy Reports 40:33-36
      Year
      1964

      Vincristine (NSC-67574) in uncommon malignant disease in children.

      Authors
      TB Haddy;DJ Fernbach;WL Watkins;MP Sullivan;J Windmiller
      Journal / Conference
      Cancer Chemotherapy Reports 41: 41-45
      Year
      1964

      Cyclophosphamide (NSC-26271) in uncommon malignant neoplasms in children.

      Authors
      TM Holcomb;ME Haggard;J Windmiller
      Journal / Conference
      Cancer Chemotherapy Reports 36:73-75
      Year
      1964